Literature DB >> 19322799

Effects of thymoquinone-fatty acid conjugates on cancer cells.

Sandra Breyer1, Katharina Effenberger, Rainer Schobert.   

Abstract

4-Acylhydrazones and 6-alkyl derivatives of thymoquinone (TQ) were tested for growth inhibition of human HL-60 leukemia, 518A2 melanoma, KB-V1/Vbl cervix, and MCF-7/Topo breast carcinoma cells. Unsaturated side chains conferred greater activities than equally long saturated chains. The number of C==C bonds was less decisive than chain length. The 6-hencosahexaenyl conjugate 3 e was most active in all resistant tumor cells, with IC(50) (72 h) values as low as 30 nM in MCF-7/Topo cells. The conjugates are likely to operate by mechanisms different from that of TQ. For instance, 3 e induced distinct caspase-independent apoptosis in HL-60 and 518A2 cells concomitant with a loss of mitochondrial membrane potential and a subsequent rise in the levels of reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322799     DOI: 10.1002/cmdc.200800430

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  10 in total

1.  Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal cancer cells.

Authors:  André Wirries; Sandra Breyer; Karl Quint; Rainer Schobert; Matthias Ocker
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

2.  In silico elucidation of the interactions of thymoquinone analogues with phosphatase and tensin homolog (PTEN).

Authors:  Leila Hokmabady; Najmeh Fani
Journal:  J Mol Model       Date:  2022-09-17       Impact factor: 2.172

Review 3.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

4.  The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression.

Authors:  Saijie Zhu; Piyanuch Wonganan; Dharmika S P Lansakara-P; Hannah L O'Mary; Yue Li; Zhengrong Cui
Journal:  Biomaterials       Date:  2012-12-20       Impact factor: 12.479

Review 5.  A review on therapeutic potential of Nigella sativa: A miracle herb.

Authors:  Aftab Ahmad; Asif Husain; Mohd Mujeeb; Shah Alam Khan; Abul Kalam Najmi; Nasir Ali Siddique; Zoheir A Damanhouri; Firoz Anwar
Journal:  Asian Pac J Trop Biomed       Date:  2013-05

6.  Synthesis of Thymoquinone-Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents.

Authors:  Tony Fröhlich; Christoph Reiter; Mohamed E M Saeed; Corina Hutterer; Friedrich Hahn; Maria Leidenberger; Oliver Friedrich; Barbara Kappes; Manfred Marschall; Thomas Efferth; Svetlana B Tsogoeva
Journal:  ACS Med Chem Lett       Date:  2017-12-21       Impact factor: 4.345

Review 7.  Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways.

Authors:  Arshad H Rahmani; Mohammad A Alzohairy; Masood A Khan; Salah M Aly
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-18       Impact factor: 2.629

Review 8.  Thymoquinone in the clinical treatment of cancer: Fact or fiction?

Authors:  Majed M Abukhader
Journal:  Pharmacogn Rev       Date:  2013-07

Review 9.  n-3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer.

Authors:  Cinzia Giordano; Pierluigi Plastina; Ines Barone; Stefania Catalano; Daniela Bonofiglio
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

10.  TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway.

Authors:  Chunli Wei; Hui Zou; Ting Xiao; Xiaoyan Liu; Qianqian Wang; Jingliang Cheng; Shangyi Fu; Jiangzhou Peng; Xin Xie; Junjiang Fu
Journal:  J Cell Mol Med       Date:  2021-10-05       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.